IL-4 as a profibrotic mediator of cardiac fibroblast differentiation through ROS and TGF-β1 signaling

Biochemical Pharmacology 2026

View at publisher
Authors: M. Catalán, F. González-Herrera, C. Suárez-Rozas, J. Landaeta-Verdejo, J.N. Ponce, C. Carrasco-Aburto, V. De León-Aravena, U. Norambuena, C. Quiroga, G. Mancilla, I. Oyarzún, M. Rodríguez
+2 more C. Rebolledo, R. Vivar
DOI: 10.1016/j.bcp.2026.118034
Cited by: 1
References: 35

Fields of Study & Subjects

Cardiac Fibrosis and Remodeling Congenital heart defects research TGF-β signaling in diseases

Publication details

Journal / source
Biochemical Pharmacology
Publisher
Elsevier BV
Volume
250
Issue
Pt 2
Pages
118034–118034
Publication date
9 May 2026
Language
EN